Showing results (391-400 of 491) with videos related to
Sort By:
Pageof 50
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trialSatish K Garg, Emily G Moser, Bruce W Bode, et al.Chemical Science|June 14, 2021
An integrated console for capsule-based, automated organic synthesisTuo Jiang, Samuele Bordi, Angus E McMillan, et al.Diabetes Care|May 10, 2017
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 TrialKeith Bowering, Christopher Case, John Harvey, et al.The EMBO Journal|June 2, 1997
The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulinA van de Locht, W Bode, R Huber, et al.Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinaseS Sperl, U Jacob, N Arroyo de Prada, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 13, 2016
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical TrialSultan Linjawi, Bruce W Bode, Louis B Chaykin, et al.Diabetes Care|May 12, 2019
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 TrialBruce W Bode, Violeta Iotova, Margarita Kovarenko, et al.Journal of Molecular Biology|August 5, 1993
Structure of human des(1-45) factor Xa at 2.2 A resolutionK Padmanabhan, K P Padmanabhan, A Tulinsky, et al.BMJ Open Diabetes Research & Care|December 15, 2020
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trialJohn B Buse, Bruce W Bode, Ann Mertens, et al.Acta Crystallographica. Section D, Biological Crystallography|February 10, 2000
Crystallization and preliminary X-ray analysis of recombinant full-length human m-calpainH Masumoto, K Nakagawa, S Irie, et al.Pageof 50